| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,§
*
Division of Rheumatology, Department of Medicine, and
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110;
Department of Pathology, University of Chicago, Chicago, IL 60637; and
§
Veteran’s Administration Medical Center, St. Louis, MO 63106
Cr2-/- mice have an impairment in humoral immunity, as shown by the decrease in the Ab titers against T cell-dependent Ags and abnormalities in germinal center formation. Germinal centers are present, but they are decreased in size and number, indicating problems in their development. In this study, we investigated whether this abnormality in germinal center development is associated with problems in the establishment of optimal affinity maturation and the generation of memory B cells, processes closely related to the germinal center reaction. We immunized the Cr2-/- animals with different Ags with or without adjuvants. We showed that, when immunized without adjuvants, complement receptors are absolutely required for optimal affinity maturation. Although limited affinity maturation is elicited in the Cr2-/- Ab response, it is decreased as compared with normal animals. Memory B cell generation is also impaired. In the presence of adjuvants, germinal center development in the Cr2-/- mice is still abnormal, as demonstrated by their decreased size and number. Surprisingly, adjuvants establish optimal affinity maturation and partially restore the amount of Ab produced during the primary response and memory B cell generation. However, adjuvants cannot improve the ability of follicular dendritic cells to retain Ags in the form of immune complexes. These observations indicate that immunization with inflammatory Ags offset some of the immunological abnormalities found in the Cr2-/- mice and show that optimal affinity maturation in the Cr2-/- mice can be achieved in the absence of normal germinal centers.
This article has been cited by other articles:
|
|
 |
|
  A. C. Jacobson and J. H. Weis Comparative Functional Evolution of Human and Mouse CR1 and CR2 J. Immunol., September 1, 2008; 181(5): 2953 - 2959. [Full Text] [PDF]
|
|
|
|
|
|
A. C. Jacobson, J. J. Weis, and J. H. Weis Complement Receptors 1 and 2 Influence the Immune Environment in a B Cell Receptor-Independent Manner J. Immunol., April 1, 2008; 180(7): 5057 - 5066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Quemeneur, V. Angeli, M. Chopin, and R. Jessberger SWAP-70 deficiency causes high-affinity plasma cell generation despite impaired germinal center formation Blood, March 1, 2008; 111(5): 2714 - 2724. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wu, S. Sukumar, M. E. El Shikh, A. M. Best, A. K. Szakal, and J. G. Tew Immune Complex-Bearing Follicular Dendritic Cells Deliver a Late Antigenic Signal That Promotes Somatic Hypermutation J. Immunol., January 1, 2008; 180(1): 281 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Jegou, P. Chan, M.-T. Schouft, M. R. Griffiths, J. W. Neal, P. Gasque, H. Vaudry, and M. Fontaine C3d Binding to the Myelin Oligodendrocyte Glycoprotein Results in an Exacerbated Experimental Autoimmune Encephalomyelitis J. Immunol., March 1, 2007; 178(5): 3323 - 3331. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Asokan, J. Hua, K. A. Young, H. J. Gould, J. P. Hannan, D. M. Kraus, G. Szakonyi, G. J. Grundy, X. S. Chen, M. K. Crow, et al. Characterization of Human Complement Receptor Type 2 (CR2/CD21) as a Receptor for IFN-{alpha}: A Potential Role in Systemic Lupus Erythematosus J. Immunol., July 1, 2006; 177(1): 383 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Del Nagro, R. V. Kolla, and R. C. Rickert A Critical Role for Complement C3d and the B Cell Coreceptor (CD19/CD21) Complex in the Initiation of Inflammatory Arthritis J. Immunol., October 15, 2005; 175(8): 5379 - 5389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, D. Perry, S. A. Boackle, E. S. Sobel, H. Molina, B. P. Croker, and L. Morel Several Genes Contribute to the Production of Autoreactive B and T Cells in the Murine Lupus Susceptibility Locus Sle1c J. Immunol., July 15, 2005; 175(2): 1080 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Birrell, L. Kulik, B. P. Morgan, V. M. Holers, and K. J. Marchbank B Cells from Mice Prematurely Expressing Human Complement Receptor Type 2 Are Unresponsive to T-Dependent Antigens J. Immunol., June 1, 2005; 174(11): 6974 - 6982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Gatto, T. Pfister, A. Jegerlehner, S. W. Martin, M. Kopf, and M. F. Bachmann Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1 J. Exp. Med., March 21, 2005; 201(6): 993 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Aguzzi, F. L Heppner, M. Heikenwalder, M. Prinz, K. Mertz, H. Seeger, and M. Glatzel Immune system and peripheral nerves in propagation of prions to CNS Br. Med. Bull., June 1, 2003; 66(1): 141 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Green, D. C. Montefiori, and T. M. Ross Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d J. Virol., February 1, 2003; 77(3): 2046 - 2055. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-B. Villiers, P. N. Marche, and C. L. Villiers Improvement of long-lasting response and antibody affinity by the complexation of antigen with complement C3b Int. Immunol., January 1, 2003; 15(1): 91 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reid, S. Woodcock, A. Shimabukuro-Vornhagen, W. G. Austen Jr., L. Kobzik, M. Zhang, H. B. Hechtman, F. D. Moore Jr., and M. C. Carroll Functional Activity of Natural Antibody is Altered in Cr2-Deficient Mice J. Immunol., November 15, 2002; 169(10): 5433 - 5440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Barrington, O. Pozdnyakova, M. R. Zafari, C. D. Benjamin, and M. C. Carroll B Lymphocyte Memory: Role of Stromal Cell Complement and Fc{gamma}RIIB Receptors J. Exp. Med., November 4, 2002; 196(9): 1189 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Marchbank, L. Kulik, M. G. Gipson, B. P. Morgan, and V. M. Holers Expression of Human Complement Receptor Type 2 (CD21) in Mice During Early B Cell Development Results in a Reduction in Mature B Cells and Hypogammaglobulinemia J. Immunol., October 1, 2002; 169(7): 3526 - 3535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Fleming, T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers Mice Deficient in Complement Receptors 1 and 2 Lack a Tissue Injury-Inducing Subset of the Natural Antibody Repertoire J. Immunol., August 15, 2002; 169(4): 2126 - 2133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, N. Jiang, C. Deppong, J. Singh, G. Dolecki, D. Mao, L. Morel, and H. D. Molina A Role for the Cr2 Gene in Modifying Autoantibody Production in Systemic Lupus Erythematosus J. Immunol., August 1, 2002; 169(3): 1587 - 1592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Guthridge, K. Young, M. G. Gipson, M.-R. Sarrias, G. Szakonyi, X. S. Chen, A. Malaspina, E. Donoghue, J. A. James, J. D. Lambris, et al. Epitope Mapping Using the X-Ray Crystallographic Structure of Complement Receptor Type 2 (CR2)/CD21: Identification of a Highly Inhibitory Monoclonal Antibody That Directly Recognizes the CR2-C3d Interface J. Immunol., November 15, 2001; 167(10): 5758 - 5766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hasegawa, M. Fujimoto, J. C. Poe, D. A. Steeber, and T. F. Tedder CD19 Can Regulate B Lymphocyte Signal Transduction Independent of Complement Activation J. Immunol., September 15, 2001; 167(6): 3190 - 3200. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
